BIONTECH SE SPON. ADRS 1
Commented by Stefan Feulner on November 20th, 2020 | 11:20 CET
BioNTech, Saturn Oil & Gas, Moderna - these stocks will explode!
Now it's all happening at once with the news in the race against the Corona pandemic. According to BioNTech and its US competitor Moderna, first deliveries of the vaccine are scheduled for the end of this year and the start of 2021. The first step towards normality, even though the head of BioNTech, Ugur Sahin, does not expect a normal social life until the end of 2021 at the earliest. Then, if everything goes smoothly, badly shaken industries should experience an unprecedented renaissance, and their share prices should take off.
Read
Commented by André Will-Laudien on November 13th, 2020 | 12:40 CET
Pfizer, BioNTech, Desert Gold - inoculate portfolios with gold!
After only three days, disillusionment already! The winners of yesterday are the losers of today. Since Monday's vaccination rocket, the markets have been hanging around up there, looking to see if any more buyers have left the sickbed of the last bear market. Unfortunately, no, the case is rather that airlines are, on average, down 5% again and a battered TUI is looking for further state aid which pushes the price back towards 4 euros. The problematic week began as the Dow rose by 4% to a new record high, and yields on ten-year government bonds shot up by almost 17% in a single day as investors relinquished security. Oil prices rose by 8% as people now believe that the stalled economy is coming back to life.
Meanwhile, the US dollar index rose by about 60 basis points, while even some exotic currencies with higher beta jumped too. Of course, some gold and silver enthusiasts wonder if a vaccine is enough to kill both the Covid-19 virus and the bull market in precious metals as gold and silver lost between 5 and 9%. However, if you look at the markets today, the chances are that smart money, in particular, will start to buy the dips in the precious metals.
Read
Commented by Stefan Feulner on November 10th, 2020 | 09:35 CET
BioNTech, RYU Apparel, TUI: Breakthroughs and unicorns!
The world is taking a deep breath, at least for now. As many had hoped, the voting out of US President Donald Trump was sealed this past weekend. Vaccination research is also progressing as a result of the corona pandemic. Despite rising case numbers, fewer resources in intensive care units, and the threat of an increased lockdown possibly beyond Christmas, there is a silver lining. People long for normality and the finer things in life.
Read
Commented by Stefan Feulner on November 9th, 2020 | 10:50 CET
BioNTech, Defense Metals, Bayer: Earn money countercyclically
It is complete. After a tense struggle and four days of counting votes, Joe Biden is declared the 46th President of the United States of America. So the Twitter tirades of the defeated Donald Trump should be history. The traces Trump left behind during his four-year reign, however, are likely to keep the government busy for some time to come. Some things, such as the withdrawal from the climate agreement, can be quickly repaired. Biden will carefully weigh up what is "in" and what is "out" on different points of the "America First" program imposed by the predecessor.
Read
Commented by Stefan Feulner on October 30th, 2020 | 09:37 CET
BioNTech, Newlox Gold, NEL ASA - get in now!
Germany in a state of shock! After the announcement of a second lockdown and a steadily increasing number of infections, the calls for a vaccine against coronavirus are getting louder and louder. The question is not when, but how quickly it will be available, especially for risk groups. Three Companies are currently heading for the home stretch. The first mover will not only get fame and recognition, but the market value of the Company will go through the roof. After the strong sell-off on the world's stock markets, there are lucrative entry opportunities.
Read
Commented by Stefan Feulner on October 21st, 2020 | 12:42 CEST
BioNTech, Valeo Pharma, Pfizer - Starting signal!
Who will make the race for the first approved Corona vaccine? Russia, China, and several North American suppliers are fighting for a place in the sun. The second and third parties should also benefit from the approval, as the demand is enormous among the nearly 8 billion inhabitants of the earth. One thing is clear; the winners of this almost macabre-sounding "Corona contest" will go through the roof. Those who receive late approval or no approval at all risk extinction. Admittedly, the world is looking at the long-awaited miracle cure. But there are easier ways for every individual to protect themselves against viruses.
Read
Commented by Nico Popp on October 16th, 2020 | 12:19 CEST
CureVac, BioNTech, Valeo Pharma: Where is there still potential?
The race for vaccines against Covid-19 is fierce. Every day there are new water level reports - from setbacks to breakthroughs, everything is there. The Tübingen-based Company CureVac recently started its phase study IIa in Peru and Panama. Around 700 people are taking part in it. The study aims to find suitable dosages for the vaccine. To this end, test persons are vaccinated twice within 28 days. Other competitors, such as BioNTech, are already testing their vaccine on more volunteers. BioNTech recently started its phase III study in South Africa and is testing the vaccine on more than 40,000 people worldwide.
Read
Commented by Stefan Feulner on October 15th, 2020 | 13:16 CEST
Bayer, Triumph Gold, BioNTech - decisive phase!
Almost everyone knows the philosophies proclaimed by the great and wise stock market gurus. “Never try catch a falling knife" or "buy on the sound of cannons, sell on the sound of trumpets”. What is true? In the case of Bayer, after the Monsanto disaster, possibly higher than planned fines and a cracking profit warning, one might think that everything has already been priced in. However, it is still not known how and when the Monsanto disaster will end. The fact is, there are other, more appealing papers at the moment ...
Read
Commented by Stefan Feulner on October 14th, 2020 | 11:40 CEST
BioNTech, BIGG, Bitcoin - The traffic lights are green!
A trend is present when the price of security tends to move in a specific direction, even under fluctuation. To play this trend correctly and to make more significant price gains, one should recognize the signals of a trend reversal. With Bitcoin & Co., this could soon be the case. The stabilization phase is still underway, but buying pressure has increased in the last few days. Companies that have a unique position in the crypto market could benefit from this.
Read
Commented by Stefan Feulner on October 9th, 2020 | 12:37 CEST
BioNTech, Barrick Gold, Velocity Minerals - Golden Times!
No! The end of the gold price increase has yet to be reached. The problems, which have become even more acute in recent months due to the pandemic, will not disappear overnight. It is understandable that the price of the precious metal will briefly collapse because "Big Donald" is saluting himself, or the helicopter pilot who brought him safely back to the White House after his short, three-day intermezzo in the military hospital. He wants to show that he has quickly left Corona behind him. However, among his many headwinds, the President now faces the US election, the still high number of Covid-19 cases in the US, the rapidly increasing national debt, and the unchecked money printing of the central banks. At least in terms of case numbers, there is positive news from BioNTech. The Corona vaccine candidate, developed by the Mainz-based company, is entering the approval phase.
Read